FPRX

Five Prime Therapeutics, Inc. Press Releases

$25.89
*  
1.61
6.63%
Get FPRX Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading FPRX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Five Prime Therapeutics to Present at the Oppenheimer 25th Annual Healthcare Conference
12/4/2014 6:59:00 PM - GlobeNewswire


Five Prime Therapeutics Initiates Patient Dosing in Phase 1 Clinical Trial Evaluating FPA144 in Gastric Cancer
12/4/2014 4:05:00 PM - GlobeNewswire


Five Prime Therapeutics to Present at The 26th Annual Piper Jaffray Healthcare Conference
11/25/2014 4:05:00 PM - GlobeNewswire


Bristol-Myers Squibb and Five Prime Therapeutics Announce Exclusive Clinical Collaboration to Evaluate the Combination of Investigational Immunotherapies Opdivo (nivolumab) and FPA008 in Six Tumor Types
11/24/2014 8:59:00 AM - GlobeNewswire


Five Prime Therapeutics Initiates Dosing of Rheumatoid Arthritis Patients in Its Phase 1 Clinical Trial of FPA008
11/17/2014 4:50:00 PM - GlobeNewswire


Five Prime Therapeutics to Present Data From Healthy Volunteer Cohorts in Phase 1 Trial of FPA008 at the 2014 ACR/ARHP Annual Scientific Meeting
11/13/2014 4:05:00 PM - GlobeNewswire


Five Prime Therapeutics Announces Third Quarter 2014 Financial Results
11/10/2014 4:19:00 PM - GlobeNewswire


Five Prime Therapeutics Announces Presentation at the 2014 Society for Immunotherapy of Cancer Annual Meeting
11/5/2014 4:05:00 PM - GlobeNewswire


Five Prime Therapeutics to Announce Third Quarter 2014 Financial Results and Host Conference Call on November 10
11/3/2014 4:29:00 PM - GlobeNewswire


Five Prime Therapeutics Announces Expansion of Respiratory Disease Research Collaboration and License Agreement With GSK
10/23/2014 4:05:00 PM - GlobeNewswire


Five Prime Therapeutics Appoints Bill Ringo to Its Board of Directors
10/2/2014 4:05:00 PM - GlobeNewswire